BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30
• 31

• Biotech Beach

  Neurocrine Biosciences to Present at the 38th Annual J.P. Morgan Healthcare Conference Live Audio Webcast will be on January 13, 2020

  Neurocrine Biosciences, Inc. will present at the 38th Annual J.P. Morgan Healthcare Conference at 11:30 a.m. Pacific Time on Monday, Jan. 13, 2020, in San Francisco. Kevin Gorman, Chief Executive Officer, will present at the conference.

  January 6, 2020

   · 

  1 min read
• Biotech Bay

  Accuray to Present at the 38th Annual J.P. Morgan Healthcare Conference on January 15, 2020

  Accuray Incorporated, announced that Joshua H. Levine, president and chief executive officer, will present at the 38th Annual J.P. Morgan Healthcare Conference on Wednesday, January 15, 2020 at 10:00 a.m. PT.

  January 6, 2020

   · 

  1 min read
• Global Active Pharmaceutical Ingredients Market 2020-2024 | Evolving Opportunities with Amneal Pharmaceuticals Inc. and Cadila Healthcare Ltd. | Technavio

  Technavio has announced its latest market research report titled global active pharmaceutical ingredients market 2020-2024.

  January 6, 2020

   · 

  4 min read
• Business

  CONMED Corporation to Announce Fourth Quarter and Full-Year 2019 Financial Results on January 29, 2020

  CONMED Corporation announced that it will report financial results for the fourth quarter and full year 2019 after the market close on Wednesday, January 29, 2020.

  January 6, 2020

   · 

  2 min read
• Business

  Rhythm Pharmaceuticals Announces Leadership Transition

  Keith Gottesdiener, M.D. to Step Down as Chief Executive Officer Following NDA Submission for Setmelanotide in POMC and LEPR Deficiency Obesities Expected in the First Quarter of 2020

  January 6, 2020

   · 

  5 min read
• Deals

  Intra-Cellular Therapies Announces Proposed Public Offering of Common Stock - Jan. 06, 2020

  Intra-Cellular Therapies, Inc., a biopharmaceutical company, announced that it has commenced an underwritten public offering of 10,000,000 shares of its common stock.

  January 6, 2020

   · 

  2 min read
• BioMidwest

  Centene To Present At 38th Annual J.P. Morgan Healthcare Conference

  Centene Corporation announced it will present at the 38th Annual J.P. Morgan Healthcare Conference, to be held at the Westin St. Francis Hotel in San Francisco, January 13-16, 2020.

  January 6, 2020

   · 

  2 min read
• Policy

  Lyra Therapeutics Announces FDA Clearance of Investigational New Drug Application for a Phase 2 Clinical Trial of LYR-210 for Chronic Rhinosinusitis

  Lyra Therapeutics, Inc. announced that the U.S. Food and Drug Administration has cleared the company’s Investigational New Drug application for LYR-210 for the treatment of chronic rhinosinusitis, a debilitating chronic disease affecting millions of patients.

  January 6, 2020

   · 

  3 min read
• Business

  Mirati Therapeutics Announces Executive Management Changes

  Appoints Dan Faga, Chief Operating Officer and Ben Hickey, Chief Commercial Officer

  January 6, 2020

   · 

  9 min read
• Global Chronic Obstructive Pulmonary Disease (COPD) Drugs Market 2019-2023 | Evolving Opportunities with AstraZeneca and Boehringer Ingelheim | Technavio

  Technavio announced its latest market research report titled global chronic obstructive pulmonary disease (COPD) drugs market 2019-2023

  January 6, 2020

   · 

  5 min read